Parkinson's disease: further steps forward.
The results of recent ongoing research in Parkinson's disease are outlined. Aspects discussed include histopathology, dementia, the MPTP animal model, methods of drug delivery, the new D2 agonist (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) and transplantation.
Rose
F C
FC
Department of Neurology, Charing Cross Hospital, London, UK.
Nashef
L
L
D000313:Adrenal Medulla / Q000637:transplantation; D000328:Adult; D000818:Animals; D003704:Dementia / Q000209:etiology; D004298:Dopamine / Q000502:physiology; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D009474:Neurons / Q000637:transplantation; D010078:Oxazines / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000235:genetics / Q000473:pathology
D008996:Monoamine Oxidase Inhibitors; D010078:Oxazines; C042631:naxagolide; D007980:Levodopa; D004298:Dopamine